|Date:||Wednesday, November 30, 2016|
|Time:||9:30 a.m. Eastern Standard Time|
|Location:||Lotte New York Palace, New York|
The timing of Schwartz' exit is noteworthy given Galena's admission on Jan. 9 of a criminal investigation of the company by the federal prosecutors into the marketing of Abstral.
Cannabis stocks are not affected by the volatility in prices during earnings season and instead trade on positive data such as potential FDA approval on their pipeline of drugs.